Biocon Limited: insider trading, SAST and pledges

No insider-trading filing for this company in the last two years.

FiledAcquirerDirectionModeAcquiredSoldHolding afterPromoter
27 Aug 2026Mylan Inc.
Reg29(2)
Sale Open Market — 91,967,019
5.64%
0.00% No
21 Jan 2026SBI Mutual Fund under its Various Schemes
Reg29(2)
Acquisition Others 33,470,117
2.21%
— 7.03% No
6 Jan 2026Mylan Inc
Reg29(1)
Acquisition Preferential Allotment 91,967,019
6.88%
— 6.88% No
13 Nov 2025SBI Mutual fund under its Various Schemes
Reg29(1)
Acquisition Others 370,150
0.03%
— 5.00% No
20 Sep 2024Life Insurance Corporation of india
Reg29(1)
Acquisition Open Market 500,000
0.04%
— 5.02% No
3 Oct 2023Kiran Mazumdar Shaw
Reg29(2)
Both Inter-se transfer 8,445,348
0.70%
— 40.36% Yes
3 Oct 2023John Mccallum Marshall Shaw
Reg29(2)
Both Inter-se transfer — 8,445,348
0.70%
0.00% Yes
23 Mar 2023Arohi Asset Management Pte. Ltd. on behalf of Funds/ SMA managed
Reg29(2)
Sale Open Market — 22,928,363
1.91%
1.57% No
13 Sep 2022Dev Mazumdar
Reg29(2)
Both Inter-se transfer 0
0.00%
897,475
0.07%
0.08% Yes
26 Nov 2021Arohi Asset Management Pte. Ltd. on behalf of Funds/ SMA managed
Reg29(1)
Acquisition Open Market 1,300,000
0.10%
— 5.07% No

Showing the most recent disclosures only. Sign in to see more, or upgrade your plan to see the full history. Sign in

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.